A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise
Status:
Withdrawn
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate that the combination of inhaled
fluticasone furoate/vilanterol (100 mcg/25 mcg) once daily provides superior protection
throughout the day against bronchoconstriction induced by exercise compared with fluticasone
propionate 250 mcg twice daily in adolescent and adult subjects aged 12 to 50 diagnosed with
persistent asthma.